(Total Views: 125)
Posted On: 06/27/2019 2:55:42 PM
Post# of 74569

$CARA News Article - Enteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Initiates Second Pruritus Phase 2 Trial of Peptelligence -Engineered Oral KORSUVA(TM) https://marketwirenews.com/news-releases/ente...24576.html


My Twitter: WhyteStocks